| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |